ISTA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference

IRVINE, CA, Apr 27 (MARKET WIRE) --
ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) today announced it will present
at the Bank of America Merrill Lynch 2011 Health Care Conference at 10:00
a.m. Pacific Time on May 11, 2011, in Las Vegas, NV. ISTA's President and
Chief Executive Officer Vicente Anido, Jr., Ph.D., will provide an update
on the company's marketed products and clinical programs.

The presentation will be webcast. To access the live audio broadcast of
the presentation, or the subsequent archived recording, log onto
http://www.istavision.com/investors.html. Please connect to the website
several minutes prior to the start of the webcast to ensure adequate time
for any software download that may be necessary.

ABOUT ISTA PHARMACEUTICALS

ISTA Pharmaceuticals, Inc. is the fourth largest and fastest growing
branded prescription eye care business in the United States, with an
expanding focus on allergy therapeutics. ISTA currently markets four
products, including treatments for ocular inflammation and pain
post-cataract surgery, glaucoma and ocular itching associated with
allergic conjunctivitis. The company's development pipeline contains
additional candidates in various stages of development to treat dry eye,
ocular inflammation and pain, and nasal allergies. Headquartered in
Irvine, California, ISTA generated revenues of $156.5 million in 2010.
For additional information about ISTA, please visit the corporate website
at www.istavision.com.

Contacts
Investor Relations Contacts at ISTA Pharmaceuticals, Inc.:
Lauren Silvernail
949-788-5302
lsilvernail@istavision.com

Jeanie Herbert
949-789-3159
jherbert@istavision.com

Media and Additional Investor Relations Contacts at Burns McClellan:
Justin Jackson
(Media)
212-213-0006
jjackson@burnsmc.com

Juliane Snowden
(Investor Relations)
212-213-0006
jsnowden@burnsmc.com

Copyright 2011, Market Wire, All rights reserved.

-0-